Page 8 - Chris Viehbacher News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Biogen Inc (NASDAQ:BIIB) Q4 2023 Earnings Call Transcript

Biogen Inc. beats earnings expectations. Reported EPS is $3.3, expectations were $3.16. Biogen Inc.

United statesChuck trianoSalveen richterChris viehbacherPaul mattiasAdam keeneyMike mcdonnellMarc goodmanEvan seigermanPriya singhalBiogen incGoldman sachsHead of corporate developmentEuropean commissionEuropean unionHead of development

Biogen, grappling with declining sales, slapped with DOJ subpoena over foreign operations

Biogen, grappling with declining sales, slapped with DOJ subpoena over foreign operations
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

Astrazeneca alexionChris viehbacherUs department of justiceExchange commissionBristol myers squibbForeign corrupt practices act

After FDA s mixed approval decisions, Sage now says it s highly encouraged by Zurzuvae launch

After FDA s mixed approval decisions, Sage now says it s highly encouraged by Zurzuvae launch
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

Kimi iguchiChris benecchiChris viehbacherBarry greeneDrug enforcement agencySage therapeuticsDrug enforcement

Biogen stock slides as quarterly results fall short of expectations

Biogen on Tuesday reported fourth-quarter results that fell short of Wall Street expectations as uptake of its newer drugs failed to offset declining.

Chris viehbacherEisai coEli lilly coBiogen incWall streetEli lillyArticle normalAgricultural machineryCommercial bankingHealthcare life sciencesBanking creditSpecialized drugs medicationsFinancial servicesIndustrial goodsNeurodegenerative disease drugsFinancial performance

Biogen Sales Miss Estimates as Multiple Sclerosis Drugs Decline

Biogen Sales Miss Estimates as Multiple Sclerosis Drugs Decline
bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomLaura chicoChris viehbacherReata pharmaceuticals incEisai coBloomberg biogen incWall streetChief executive officer chris viehbacherWedbush securities